Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Quickly find providers of hospital management software solutions.
Popular Articles
Natural Remedies

Coalition To Protect Patients' Rights Urges Congress To Slow Down Health Reform And Do It Right
Dr. Donald Palmisano, former president of the American Medical Association and current spokesman for the Coalition to Protect Patients" Rights (Coalition) and over forty doctors from across the country today urged Members of Congress to slow down health system reform and do it right. The Coalition held a press conference at the National Press Club to urge legislators to put patients first when developing a system overhaul.
generic viagra online
46 R&D 100 Awards For 2009 Won By DOE-Funded Research Projects
U.S. Secretary of Energy Steven Chu has announced that Energy Department-funded researchers have won 46 of the 100 awards given out this year by R&D Magazine for the most outstanding technology developments with promising commercial potential. The coveted awards are presented annually in recognition of exceptional new products, processes, materials or software developed throughout the world and introduced into the market the previous year.
News of the day
Toshiba Introduces New Multi-Detector CT Systems
Toshiba America Medical Systems, Inc. introduces two advanced multi-detector CT systems, the Aquilion® Premium edition and the Aquilion CX edition. The Aquilion Premium rounds out the company"s CT portfolio to include a product with 160-detector rows and coverage up to 8 cm in a single rotation. This system is also field-upgradeable to an Aquilion ONE. The Aquilion CX is Toshiba"s next generation 64-detector row CT system featuring faster reconstruction standards with up to 28 images per second, Toshiba"s proven Quantum Advantage detector technology and a patient couch that can accommodate up to 660 lbs. The Aquilion Premium and Aquilion CX are both available now.
Health Insurance

Androgen-Receptor: A New Drug Target In Breast Cancer

New results may help scientists develop treatments for women with a type of breast cancer that currently does not respond to targeted therapies. Some cancers (triple-negative tumors) generally do not respond to receptor-targeted treatments. In recent years, scientists have begun looking for new targets in these "triple-negative" cancers. One that has been identified is the androgen-receptor. European Society for Medical Oncology


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009